Constantine S. Tam
0000-0002-9759-5017
Publication & Citation Trends
Publications
0 total
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.
Cited by 0
Semantic Scholar
Expert consensus opinion on the management of hairy cell leukemia in elderly patients
Cited by 0
Semantic Scholar
Abstract 3199: Radiomic features associated with anti-tumor activity in Non-Hodgkin lymphoma patients treated with CD19 directed allogenic CAR T therapy
Cited by 0
Semantic Scholar
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study
Cited by 0
Semantic Scholar
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions OA
Cited by 16
Semantic Scholar
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon OA
Cited by 15
Semantic Scholar
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O008) OA
Cited by 0
Semantic Scholar
Australia and New Zealand consensus position statement: use of COVID‐19 therapeutics in patients with haematological malignancies OA
Cited by 1
Semantic Scholar
Correction: Zanubrutinib: past, present, and future OA
Cited by 2
Semantic Scholar
Chronic lymphocytic leukaemia Australasian consensus practice statement OA
Cited by 9
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(665)
Lymphoma Diagnosis and Treatment
(446)
Chronic Myeloid Leukemia Treatments
(151)
Immunodeficiency and Autoimmune Disorders
(127)
CAR-T cell therapy research
(92)
Affiliations
Roswell Park Comprehensive Cancer Center
St. Vincent's Birmingham
The Royal Melbourne Hospital
Karolinska University Hospital
The University of Texas MD Anderson Cancer Center